hidradenitis suppurativa


Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.
Translations

hidradenitis suppurativa

n hidradenitis supurativa, inflamación f e infección f de las glándulas sudoríporas de las axilas o de la ingle
References in periodicals archive ?
ChemoCentryx is also developing avacopan for the treatment of patients with C3 glomerulopathy (C3G) and hidradenitis suppurativa (HS).
9, 2019 (HealthDay News) -- In a two-part guideline, published in the July issue of the Journal of the American Academy of Dermatology, the United States and Canadian Hidradenitis Suppurativa Foundations present recommendations for the diagnosis, evaluation, and management of hidradenitis suppurativa.
M2 PRESSWIRE-August 8, 2019-: Hidradenitis Suppurativa Pipeline Review, H1 2019 Report
The purpose of this study is to investigate the safety and efficacy of IFX-1, a first-in-class anti-human complement factor C5a monoclonal antibody, in patients suffering from moderate to severe Hidradenitis Suppurativa (HS), a painful and debilitating chronic inflammatory skin disease with limited treatment options.
Rigorous evidence is unavailable for most interventions for treating hidradenitis suppurativa (HS), so management needs to be individualized, according to the first North American guidelines from the United States and Canadian Hidradenitis Suppurativa Foundations for the management and treatment of the disorder.
In the case of pediatric hidradenitis suppurativa, the disease itself may be hidden from view by reticent teens; once diagnosed, providers must remain vigilant for occult associations including precocious puberty and polycystic ovarian syndrome.
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease, characterized by the presence of painful nodules and abscesses in apocrine gland-bearing areas (1-3).
The author of this report has worked with 47 patients with hidradenitis suppurativa who followed his recommendation to eliminate dairy products from their diet.
* HiSCR stands for Hidradenitis Suppurativa Clinical Response, and is defined as at least a 50% reduction from baseline in the abscess and inflammatory nodule counts, with no increase in abscess or draining-fistula counts.
The symposium will include speakers and a presentation on hidradenitis suppurativa, a chronic skin disease with a higher prevalence in patients with skin of color, particularly African-Americans and Hispanics.
ChemoCentryx is also developing avacopan for the treatment of patients with C3 glomerulopathy and hidradenitis suppurativa. The US Food and Drug Administration has granted avacopan orphan-drug designation for ANCA-associated Vasculitis, C3G and atypical hemolytic uremic syndrome.